Allergan

Allergan was a global pharmaceutical company best known for its aesthetic products, including Botox, and its treatments for eye care, central nervous system disorders, and other medical specialties.

History: Originally founded in 1948 as a small Southern California pharmacy, Allergan grew through strategic acquisitions and product development. Key milestones included the development and marketing of Botox (botulinum toxin type A) for various medical and cosmetic uses.

Products and Services: Allergan's diverse portfolio included:

• Aesthetics: Botox Cosmetic, Juvederm family of dermal fillers, CoolSculpting body contouring system, and other products related to facial aesthetics and body shaping.
• Eye Care: Treatments for glaucoma, dry eye disease (Restasis), and other ophthalmic conditions.
• Central Nervous System: Treatments for migraine and other neurological disorders.
• Other Therapeutic Areas: Products for gastroenterology, urology, and women's health.

Acquisition by AbbVie: In 2020, Allergan was acquired by AbbVie, a global biopharmaceutical company. The Allergan name is no longer used as a separate entity; its products and operations are integrated into AbbVie's portfolio. The acquisition significantly expanded AbbVie's presence in aesthetics and eye care.

Legacy: While the Allergan company no longer exists independently, its legacy continues through the products and treatments now marketed by AbbVie. Its innovations in aesthetic medicine and its contributions to various therapeutic areas remain significant. The brand names of its key products, like Botox and Juvederm, are still widely recognized and used.